[Qualitative detection of hepatitis C virus core antigen in the serum in patients with chronic hepatitis C]

Yi Ouyang1, De-ming Tan, Tie-gang Li

  • 1Departerment of Infectious Disease, Xiangya Hospital, Central South University, Changsha 410078, China.

Insights

Serum hepatitis C virus (HCV) core antigen detected by ELISA shows high specificity and is related to HCV RNA. This marker may be useful for detecting HCV viraemia in patients with chronic hepatitis C.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Context:

  • Hepatitis C virus (HCV) infection remains a significant global health concern.
  • Accurate and accessible diagnostic markers are crucial for managing chronic hepatitis C.
  • Enzyme-linked immunosorbent assay (ELISA) is a widely used diagnostic technique.

Purpose:

  • To evaluate the clinical significance of serum hepatitis C virus (HCV) core antigen detected by ELISA.
  • To assess the specificity and correlation of HCV core antigen with HCV RNA and anti-HCV antibodies.

Summary:

  • Serum HCV core antigen was detected using ELISA in 149 patients with chronic hepatitis C, 20 with chronic hepatitis B, and 20 healthy volunteers.
  • HCV core antigen was negative in all patients with chronic hepatitis B and healthy volunteers, indicating high specificity.
  • The positive rate of HCV core antigen in chronic hepatitis C patients was 49.66%, showing a correlation with HCV RNA levels.

Impact:

  • HCV core antigen detected by ELISA demonstrates high specificity.
  • The positive percentage of HCV core antigen in chronic hepatitis C patients is 49.66%.
  • HCV core antigen serves as a potential serum marker for detecting HCV viraemia, similar to HCV RNA.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...